UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020566
Receipt number R000023746
Scientific Title Examination of dopaminergic system using neurofeedback technique
Date of disclosure of the study information 2016/02/01
Last modified on 2016/10/31 11:26:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of dopaminergic system using neurofeedback technique

Acronym

Examination of dopaminergic system using neurofeedback technique

Scientific Title

Examination of dopaminergic system using neurofeedback technique

Scientific Title:Acronym

Examination of dopaminergic system using neurofeedback technique

Region

Japan


Condition

Condition

Healthy individuals

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the correlation between the neural modulation by neurofeedback training and the intensity of dopamine receptors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The correlation between the change of BOLD signals, the psychological changes and the intensity of dopamine receptor

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Behavior,custom

Interventions/Control_1

(1) Psychophysiological measurements
Day1: 60 min in twice
Day3: 60 min in twice

(2) Structural MRI
Day1: 20 min
Day3: 20 min

(3) Functional MRI
Day1: 120 min
Day3: 120 min

(4) PET scan
Day2: [11C] raclopride (6mCi, single injection)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

Healthy individuals who have the ability to provide informed consent.

Key exclusion criteria

Psychiatric disorders including drug dependence
Serious medical illness

Target sample size

16


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makiko Yamada

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

043-206-3251

Email

myamada@nirs.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuko Suzuki

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

043-206-3025

Homepage URL


Email

khsuzuki@nirs.go.jp


Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

National Institute of Radiological Sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 12 Month 14 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 01 Month 14 Day

Last modified on

2016 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023746


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name